GlassScriptPhysician profile
George J Friedhoff
NPI 1043522634
$3,778.12
in general payments reported to CMS, 2019-2025
46 companies · $54.62 in 2025
The $54.62 reported for 2025 was less than what a typical Sports Medicine (Internal Medicine) provider received nationally (typical 2025 total: $99.49).
See the full distribution for Sports Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $418 · 2020: $310 · 2021: $782 · 2022: $554 · 2023: $735 · 2024: $926 · 2025: $54.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,715.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,714.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $538.17 | 2021-2025 | |
| Horizon Therapeutics Plc | $284.65 | 2019-2021 | |
| Amgen INC. | $231.61 | 2019-2021 | |
| Abbott Laboratories | $180.72 | 2021-2024 | Freestyle Libre 3 |
| Medtronic, INC. | $178.41 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $167.35 | 2022 | |
| Gilead Sciences, INC. | $142.41 | 2023-2024 | Veklury |
| Astrazeneca Pharmaceuticals LP | $124.87 | 2024 | Airsupra |
| Pacira Therapeutics, INC. | $122.64 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $121.85 | 2023-2024 | Rexulti |
| Exact Sciences Corporation | $107.57 | 2023-2024 | Cologuard Collection Kit |
| Novo Nordisk INC | $98.15 | 2020-2024 | Wegovy |
| Xeris Pharmaceuticals, INC. | $93.58 | 2023-2024 | Gvoke Hypopen, Keveyis |
| Jazz Pharmaceuticals INC. | $93.11 | 2020-2022 | |
| Lundbeck LLC | $93.04 | 2023-2024 | Rexulti |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Friedhoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.